See more : Alfa, S. A. B. de C. V. (ALFFF) Income Statement Analysis – Financial Results
Complete financial analysis of XOMA Corporation (XOMA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of XOMA Corporation, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Worldwide Strategies, Inc. (WWSG) Income Statement Analysis – Financial Results
- Energroup Holdings Corp. (ENHD) Income Statement Analysis – Financial Results
- Signature Leisure, Inc. (SGLS) Income Statement Analysis – Financial Results
- SmarTone Telecommunications Holdings Limited (0315.HK) Income Statement Analysis – Financial Results
- News Corporation (NWSAL) Income Statement Analysis – Financial Results
XOMA Corporation (XOMA)
About XOMA Corporation
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.76M | 6.03M | 38.16M | 29.39M | 18.37M | 5.30M | 52.69M | 5.56M | 55.45M | 18.87M | 35.45M | 33.78M | 58.20M | 33.64M | 98.43M | 67.99M | 84.25M | 29.50M | 18.67M | 3.67M | 24.41M | 29.95M | 17.28M | 6.66M | 2.40M | 6.30M | 18.40M | 3.60M | 1.20M | 1.70M | 600.00K | 5.10M | 17.10M | 20.50M | 10.40M | 5.00M | 7.70M | 100.00K | 7.30M |
| Cost of Revenue | 897.00K | 97.00K | 171.00K | 170.00K | 1.25M | 1.68M | 7.88M | 1.40M | 20.70M | 29.47M | 27.36M | 143.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.37M | 0.00 | 0.00 | 0.00 | 1.87M | -1.20M | -1.60M | -2.00M | -2.10M | -2.90M | -3.30M | -2.60M | -800.00K | 6.50M | 5.60M | 24.20M | 14.50M | -1.40M | 41.40M | 8.50M |
| Gross Profit | 3.86M | 5.93M | 37.99M | 29.22M | 17.12M | 3.62M | 44.82M | 4.16M | 34.75M | -10.60M | 8.09M | 33.64M | 58.20M | 33.64M | 98.43M | 67.99M | 84.25M | 29.50M | 18.67M | -12.71M | 24.41M | 29.95M | 17.28M | 4.79M | 3.60M | 7.90M | 20.40M | 5.70M | 4.10M | 5.00M | 3.20M | 5.90M | 10.60M | 14.90M | -13.80M | -9.50M | 9.10M | -41.30M | -1.20M |
| Gross Profit Ratio | 81.15% | 98.39% | 99.55% | 99.42% | 93.18% | 68.26% | 85.05% | 74.84% | 62.67% | -56.19% | 22.82% | 99.58% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | -346.74% | 100.00% | 100.00% | 100.00% | 71.93% | 150.00% | 125.40% | 110.87% | 158.33% | 341.67% | 294.12% | 533.33% | 115.69% | 61.99% | 72.68% | -132.69% | -190.00% | 118.18% | -41,300.00% | -16.44% |
| Research & Development | 143.00K | 153.00K | 171.00K | 170.00K | 1.25M | 1.68M | 7.88M | 44.23M | 70.85M | 80.75M | 74.85M | 68.32M | 68.14M | 77.41M | 58.13M | 82.58M | 66.22M | 52.09M | 39.90M | 49.78M | 57.46M | 42.62M | 35.93M | 30.01M | 41.50M | 43.80M | 29.90M | 26.40M | 22.10M | 27.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.61M | 23.19M | 20.46M | 16.80M | 21.00M | 18.56M | 24.34M | 18.32M | 20.62M | 19.87M | 18.48M | 16.87M | 24.01M | 23.25M | 23.74M | 24.15M | 20.58M | 18.09M | 14.80M | 31.98M | 24.49M | 19.41M | 8.68M | 6.07M | 6.10M | 5.40M | 5.60M | 5.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 25.61M | 23.19M | 20.46M | 16.80M | 21.00M | 18.56M | 24.34M | 18.32M | 20.62M | 19.87M | 18.48M | 16.87M | 24.01M | 23.25M | 23.74M | 24.15M | 20.58M | 18.09M | 14.80M | 31.98M | 24.49M | 19.41M | 8.68M | 6.07M | 6.10M | 5.40M | 5.60M | 5.50M | 5.40M | 8.70M | 35.10M | 41.80M | 49.90M | 37.80M | 7.50M | 3.90M | 13.00M | 4.00M | 3.00M |
| Other Expenses | 19.96M | 97.00K | -879.00K | 1.23M | 3.82M | 4.34M | 1.12M | 1.51M | 44.00K | -31.00K | -197.00K | -956.00K | 0.00 | 82.00K | 3.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.87M | 1.20M | 1.60M | 2.00M | 2.10M | 2.90M | 3.30M | 2.80M | 3.00M | 2.00M | 1.80M | 1.40M | 800.00K | 1.40M | 2.00M | 1.40M |
| Operating Expenses | 45.71M | 23.44M | 20.63M | 16.97M | 22.26M | 20.25M | 32.21M | 62.56M | 91.47M | 100.61M | 93.33M | 85.19M | 92.15M | 100.66M | 81.87M | 106.72M | 86.80M | 70.18M | 54.69M | 81.76M | 81.95M | 62.03M | 44.61M | 34.21M | 48.80M | 50.80M | 37.50M | 34.00M | 30.40M | 39.30M | 37.90M | 44.80M | 51.90M | 39.60M | 8.90M | 4.70M | 14.40M | 6.00M | 4.40M |
| Cost & Expenses | 46.61M | 23.44M | 20.63M | 16.97M | 22.26M | 20.25M | 32.21M | 62.56M | 91.47M | 100.61M | 93.33M | 85.33M | 92.15M | 100.66M | 81.87M | 106.72M | 86.80M | 70.18M | 54.69M | 81.76M | 81.95M | 62.03M | 44.61M | 36.08M | 47.60M | 49.20M | 35.50M | 31.90M | 27.50M | 36.00M | 35.30M | 44.00M | 58.40M | 45.20M | 33.10M | 19.20M | 13.00M | 47.40M | 12.90M |
| Interest Income | 0.00 | 0.00 | 35.00K | 159.00K | 1.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.00K | 49.00K | 859.00K | 0.00 | 1.68M | 1.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 569.00K | 0.00 | 461.00K | 1.84M | 1.92M | 922.00K | 1.24M | 3.95M | 4.18M | 4.28M | 4.63M | 4.34M | 2.46M | 385.00K | 4.89M | 7.00M | 0.00 | 12.93M | 4.25M | 0.00 | 1.88M | 0.00 | 0.00 | 2.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 900.00K | 274.00K | 167.00K | 172.00K | 1.92M | 30.00K | 304.00K | 769.00K | 1.53M | 1.86M | 2.58M | 4.12M | 5.36M | 5.72M | 6.83M | 8.12M | 6.73M | 6.17M | 5.77M | 4.55M | 3.99M | 2.12M | 1.25M | -1.87M | 1.20M | 1.60M | 2.00M | 2.10M | 2.90M | 3.30M | 2.80M | 3.00M | 2.00M | 1.80M | 1.40M | 800.00K | 1.40M | 2.00M | 1.40M |
| EBITDA | -39.36M | -16.85M | 16.52M | 13.81M | 1.85M | -12.49M | 20.78M | -48.82M | -15.31M | -32.14M | -116.87M | -62.63M | -24.91M | -62.62M | 18.00M | -31.91M | 4.19M | -34.51M | -36.03M | -73.16M | -53.55M | -29.96M | -26.08M | -31.29M | -44.00M | -41.30M | -15.20M | -26.20M | -23.40M | -31.00M | -31.90M | -35.90M | -39.30M | -22.90M | -21.30M | -13.40M | -3.90M | -45.30M | -4.20M |
| EBITDA Ratio | -827.28% | -282.31% | 43.63% | 46.42% | -0.34% | -200.19% | 40.98% | -997.16% | -62.15% | -423.76% | -163.81% | -143.35% | -49.14% | -182.17% | 23.82% | -44.89% | 5.05% | -117.34% | -382.61% | -2,017.08% | -222.46% | -102.94% | -162.25% | -510.12% | -1,883.33% | -552.38% | -89.67% | -702.78% | -2,266.67% | -1,805.88% | -5,916.67% | -549.02% | -281.29% | -145.37% | -290.38% | -344.00% | -57.14% | -47,200.00% | -68.49% |
| Operating Income | -41.85M | -17.41M | 17.53M | 12.42M | -3.89M | -16.86M | 17.03M | -61.56M | -39.72M | -81.83M | -58.21M | -56.62M | -33.96M | -67.10M | 12.96M | -38.73M | -2.54M | -40.68M | -36.03M | -78.10M | -57.54M | -32.08M | -27.33M | -29.42M | -45.20M | -42.90M | -17.10M | -28.30M | -26.30M | -34.30M | -34.70M | -38.90M | -41.30M | -24.70M | -22.70M | -14.20M | -5.30M | -47.30M | -5.60M |
| Operating Income Ratio | -879.53% | -288.93% | 45.94% | 42.25% | -21.15% | -318.12% | 32.32% | -1,106.36% | -71.64% | -433.75% | -164.18% | -167.62% | -58.35% | -199.47% | 13.17% | -56.97% | -3.02% | -137.92% | -192.97% | -2,130.86% | -235.70% | -107.11% | -158.17% | -441.75% | -1,883.33% | -680.95% | -92.93% | -786.11% | -2,191.67% | -2,017.65% | -5,783.33% | -762.75% | -241.52% | -120.49% | -218.27% | -284.00% | -68.83% | -47,300.00% | -76.71% |
| Total Other Income/Expenses | 1.02M | 295.00K | -1.64M | -619.00K | 1.90M | 3.42M | -773.00K | 8.03M | 19.12M | 43.53M | -65.87M | -14.52M | 1.23M | -1.63M | -6.68M | -6.89M | -9.78M | -11.16M | 38.81M | -846.00K | -1.12M | 871.00K | 1.96M | 2.68M | 1.20M | -6.50M | 1.50M | -900.00K | 3.80M | -300.00K | 3.60M | -7.90M | 8.80M | 6.90M | 8.90M | 3.80M | 500.00K | 1.90M | 800.00K |
| Income Before Tax | -40.83M | -17.12M | 15.89M | 11.80M | -1.98M | -13.44M | 16.26M | -53.53M | -20.61M | -38.30M | -124.07M | -71.14M | -32.73M | -68.73M | 6.28M | -45.63M | -12.33M | -51.84M | 2.78M | -78.94M | -58.65M | -31.21M | -25.37M | -26.73M | -44.00M | -49.40M | -15.70M | -29.20M | -22.50M | -34.60M | -31.10M | -46.80M | -32.50M | -17.80M | -13.80M | -10.40M | -4.80M | -45.40M | -4.80M |
| Income Before Tax Ratio | -858.15% | -284.04% | 41.64% | 40.15% | -10.79% | -253.65% | 30.86% | -962.08% | -37.16% | -203.02% | -349.98% | -210.58% | -56.24% | -204.30% | 6.38% | -67.11% | -14.63% | -175.74% | 14.90% | -2,153.94% | -240.26% | -104.20% | -146.84% | -401.44% | -1,833.33% | -784.13% | -85.33% | -811.11% | -1,875.00% | -2,035.29% | -5,183.33% | -917.65% | -190.06% | -86.83% | -132.69% | -208.00% | -62.34% | -45,400.00% | -65.75% |
| Income Tax Expense | 0.00 | -15.00K | 91.00K | -1.50M | 5.72M | -98.00K | 1.66M | 4.69M | 4.23M | 4.25M | -14.00K | -74.00K | 15.00K | 27.00K | 5.73M | -383.00K | 9.78M | 11.16M | 3.00K | 846.00K | 1.12M | 1.17M | 709.00K | -4.00K | 600.00K | 4.30M | -1.30M | 800.00K | -3.80M | 300.00K | -3.40M | 8.20M | -7.00M | -1.00M | -3.80M | -2.20M | -500.00K | -600.00K | -800.00K |
| Net Income | -40.83M | -17.10M | 15.80M | 13.30M | -7.70M | -13.34M | 14.60M | -53.53M | -20.61M | -38.30M | -124.06M | -71.07M | -32.74M | -68.76M | 550.00K | -45.25M | -12.33M | -51.84M | 2.78M | -78.94M | -58.65M | -33.25M | -28.04M | -29.41M | -45.80M | -47.20M | -15.80M | -29.10M | -22.50M | -34.60M | -31.30M | -47.10M | -34.30M | -23.70M | -18.90M | -12.00M | -4.80M | -46.70M | -4.80M |
| Net Income Ratio | -858.15% | -283.79% | 41.40% | 45.25% | -41.91% | -251.80% | 27.70% | -962.08% | -37.16% | -203.02% | -349.94% | -210.36% | -56.26% | -204.38% | 0.56% | -66.55% | -14.63% | -175.74% | 14.89% | -2,153.94% | -240.26% | -111.01% | -162.28% | -441.69% | -1,908.33% | -749.21% | -85.87% | -808.33% | -1,875.00% | -2,035.29% | -5,216.67% | -923.53% | -200.58% | -115.61% | -181.73% | -240.00% | -62.34% | -46,700.00% | -65.75% |
| EPS | -4.04 | -1.50 | 1.40 | 1.25 | -0.88 | -1.59 | 0.75 | -8.89 | -3.50 | -7.13 | -28.60 | -22.00 | -20.73 | -73.88 | 1.00 | -102.11 | -28.90 | -162.07 | 9.00 | -279.09 | -234.39 | -141.77 | -123.42 | -136.34 | -260.70 | -330.11 | -119.86 | -268.67 | -285.16 | -474.00 | -438.00 | -660.00 | -531.00 | -504.00 | -429.00 | -336.00 | -165.06 | -1.91K | -171.00 |
| EPS Diluted | -4.04 | -1.50 | 1.30 | 1.16 | -0.88 | -1.59 | 0.73 | -8.89 | -3.50 | -6.64 | -28.54 | -21.99 | -20.73 | -73.88 | 0.97 | -102.11 | -28.90 | -162.07 | 9.00 | -279.09 | -234.39 | -141.77 | -123.42 | -136.34 | -260.70 | -330.11 | -119.86 | -268.67 | -285.16 | -474.00 | -438.00 | -660.00 | -531.00 | -504.00 | -429.00 | -336.00 | -165.06 | -1.91K | -171.00 |
| Weighted Avg Shares Out | 11.47M | 11.41M | 11.29M | 10.67M | 8.76M | 8.37M | 7.62M | 6.02M | 5.89M | 5.37M | 4.34M | 3.23M | 1.58M | 930.65K | 549.65K | 443.10K | 426.49K | 319.87K | 287.14K | 282.86K | 250.23K | 234.52K | 227.20K | 215.73K | 175.68K | 142.98K | 131.82K | 108.31K | 78.90K | 73.00K | 71.46K | 71.36K | 64.60K | 47.02K | 44.06K | 35.71K | 29.08K | 24.48K | 28.07K |
| Weighted Avg Shares Out (Dil) | 11.47M | 11.41M | 12.19M | 11.50M | 8.76M | 8.37M | 7.98M | 6.02M | 5.89M | 5.77M | 4.35M | 3.23M | 1.58M | 930.65K | 565.65K | 443.10K | 426.49K | 319.87K | 300.21K | 282.86K | 250.23K | 234.52K | 227.20K | 215.73K | 175.68K | 142.98K | 131.82K | 108.31K | 78.90K | 73.00K | 71.46K | 71.36K | 64.60K | 47.02K | 44.06K | 35.71K | 29.08K | 24.48K | 28.07K |
What Makes XOMA Royalty (XOMA) a New Buy Stock
XOMA Royalty (XOMA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates
XOMA Royalty (XOMA) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.60 per share a year ago.
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
Zevra's MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty's portfolio
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
XOMA Royalty has acquired 50 percent of Twist's existing royalty and milestone economics for $15 million XOMA Royalty's portfolio now holds over 100 assets ranging from revenue-generating commercial therapeutics to pre-clinical programs EMERYVILLE, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) --...
XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties
XOMA Royalty Corporation offers diversified revenue streams from milestone and royalty rights in various therapeutic areas, providing stable returns with lower clinical trial risks. The company's preferred shares, XOMAP and XOMAO, offer high, reliable dividends, making them attractive for income...
I Am Banking On The Silver Tsunami With Big Dividends
There are sectors that experience demand irrespective of economic climate. I like cold hard cash placed in my account. We discuss big dividends from healthcare, yields +8.3%.
XOMA Stock Dips Amidst Biotech Sector Decline
XOMA (XOMA, Financial), a company engaged in biotechnology royalties, saw its stock price plummet by 5.36%, with the latest price reported at $25.91. The trading volume reached 3,638 shares, representing a turnover rate of 0.03% and a price fluctuation amplitude...
XOMA Royalty Declares Quarterly Preferred Stock Dividends
EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA's Series A and Series B Cumulative Preferred...
XOMA Royalty to Present at Upcoming Investor Conferences in September
EMERYVILLE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following September 2024 investor conferences:
XOMA Royalty (XOMA) Reports Q2 Loss, Tops Revenue Estimates
XOMA Royalty (XOMA) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.59 per share a year ago.
Source: https://incomestatements.info
Category: Stock Reports